Heart Health High Cholesterol Treatment Who Should Take Statin Drugs and When By Richard N. Fogoros, MD Richard N. Fogoros, MD Facebook LinkedIn Richard N. Fogoros, MD, is a retired professor of medicine and board-certified in internal medicine, clinical cardiology, and clinical electrophysiology. Learn about our editorial process Updated on February 02, 2023 Medically reviewed by Yasmine S. Ali, MD, MSCI Medically reviewed by Yasmine S. Ali, MD, MSCI Facebook LinkedIn Twitter Yasmine Ali, MD, is board-certified in cardiology. She is an assistant clinical professor of medicine at Vanderbilt University School of Medicine and an award-winning physician writer. Learn about our Medical Expert Board Print Statin drugs are among the most commonly prescribed medications in the U.S. with annual sales of over $18 billion, according to research from the Northwestern University Feinberg School of Medicine in Chicago. Pascal Broze / ONOKY / Getty Images Statin drugs are known to significantly reduce the odds of having a heart attack or stroke by lowering the level of "bad" cholesterol in the blood. But they are no longer prescribed based solely on a person's blood test results. Today, statin drugs are used when has a person has a 7.5% or greater risk of having a heart attack or stroke over the next 10 years, or to patients who have known cardiovascular disease. List of Approved Statin Drugs Eleven statin medications are currently approved by the U.S. Food and Drug Administration, including four fixed-dose combination drugs. The seven primary drug agents are: Lipitor (Atorvastatin)Lescol (Fluvastatin)Mevacor (Lovastatin)Livalo (Pitavastatin)Pravachol (Pravastatin)Zocor (Simvastatin)Crestor (Rosuvastatin) Low-cost generic versions are also available. Benefits of Statin Drugs Statin drugs lower cholesterol levels by inhibiting a liver enzyme, known as HMG Co-A reductase, which is key to cholesterol synthesis. The consistent use of these drugs is associated with a significant reduction in "bad" LDL cholesterol, a moderate reduction in triglycerides, and a small increase in "good" HDL cholesterol. These effects translate to additional cardiovascular benefits, including: A reduction in the buildup of plaque on the walls of the arteriesThe stabilization of plaques so that they don't break off and cause an arterial obstruction in the heart or brainDecreased arterial inflammation as measured by the C-reactive protein (CRP) testDecreased blood clot formation at the site of an obstruction These effects can also help reduce blood pressure, particularly in people with prehypertension who are not yet on blood pressure medication. Common Side Effects of Statins While statin drugs offer significant benefits to people at risk of cardiovascular disease, there may be side effects associated with their use. Most are mild to moderate in severity and typically resolve once the body adjusts to the treatment. The most common include: NauseaGasUpset stomachHeadacheDizzinessFatigueRashSleep disturbanceReduced concentrationMuscle aches Statins can also cause an elevation in liver enzymes in one of every 100 users. In most cases, this increase is not associated with serious or permanent liver damage, but care needs to be taken if statins are prescribed to people with underlying liver dysfunction. Statins also appear to increase the risk of developing type II diabetes in some, most especially postmenopausal women. Who Should and Should Not Take Statins There has been some contention over the years as to whether statins are necessary or equally beneficial in all groups. This has been misconstrued by some as meaning that statins have no benefit and, worse yet, maybe harmful. This is not true. In 2016, the government's U.S. Preventive Services Task Force (USPSTF) issued updated guidelines simply stating that the evidence was " insufficient" to recommend starting statins in people 76 and older who didn't have a history of heart attack or stroke. The American Heart Association and American College of Cardiology also reflect this update in their 2018 guidelines. The statement by USPSTF was neither a rebuke of statins in this group nor a suggestion that people should stop taking their statin medications once they turn 76. Rather, it suggests that the benefits may be smaller and that clinical judgment needs to be made on a case-by-case basis. The USPSTF further issued recommendations regarding the use of statins in the following risk groups: Treatment with low- to moderate-dose statins is recommended for adults 40 to 75 who haven't had a heart attack or stroke but are at risk of one. The determination is made based on whether the person has one or more risk factors for cardiovascular disease and a greater than 7.5% calculated risk of a heart attack or stroke in the next 10 years.Treatment may also be started, with clinical judgment, in adults of the same age group who have one or more cardiovascular risk factors and calculated risk between 7.5 and 10%. 6 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. American College of Cardiology. 2018 Guideline on the Management of Blood Cholesterol. Kellick KA, Bottorff M, Toth PP. A clinicians guide to statin drug-drug interactions. Journal of Clinical Lipidology. 2014;8(3). doi:10.1016/j.jacl.2014.02.010 Endo A. A historical perspective on the discovery of statins. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(5):484–493. doi:10.2183/pjab.86.484 Mills EJ, Wu P, Chong G. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials. Qjm. 2010;104(2):109-124. doi:10.1093/qjmed/hcq165 Newman CB, Preiss D, Tobert JA. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology. 2019;39(2). doi:10.1161/atv.0000000000000073 Bibbins-Domingo K, Grossman DC, Curry SJ. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults. Jama. 2016;316(19):1997. doi:10.1001/jama.2016.15450 Additional Reading Taylor F, Huffman M, Ebrahim S. Statin therapy for primary prevention of cardiovascular disease. JAMA. 2013; 310(22):2451-2452. doi:10.1001/jama.2013.281348 By Richard N. Fogoros, MD Richard N. Fogoros, MD, is a retired professor of medicine and board-certified in internal medicine, clinical cardiology, and clinical electrophysiology. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit